"Hemorrhage" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Bleeding or escape of blood from a vessel.
Descriptor ID |
D006470
|
MeSH Number(s) |
C23.550.414
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hemorrhage".
Below are MeSH descriptors whose meaning is more specific than "Hemorrhage".
This graph shows the total number of publications written about "Hemorrhage" by people in this website by year, and whether "Hemorrhage" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 0 | 1 | 1 |
2001 | 1 | 1 | 2 |
2002 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2005 | 2 | 0 | 2 |
2006 | 1 | 0 | 1 |
2007 | 1 | 1 | 2 |
2008 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2011 | 1 | 1 | 2 |
2012 | 0 | 5 | 5 |
2013 | 1 | 3 | 4 |
2014 | 4 | 1 | 5 |
2015 | 2 | 1 | 3 |
2016 | 2 | 1 | 3 |
2017 | 1 | 6 | 7 |
2018 | 0 | 2 | 2 |
2019 | 0 | 3 | 3 |
2020 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemorrhage" by people in Profiles.
-
Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment. Blood Adv. 2020 06 23; 4(12):2557-2566.
-
Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis. Blood. 2020 05 14; 135(20):1788-1810.
-
Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2019 12; 12(12):e007612.
-
Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation. Circ Cardiovasc Qual Outcomes. 2019 11; 12(11):e006212.
-
Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II. Am Heart J. 2019 07; 213:81-90.
-
Are We There Yet? Another Milepost in the Journey to Identify Appropriate Candidates for Aspirin Primary Prevention. Ann Intern Med. 2019 03 19; 170(6):411-413.
-
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. J Thromb Thrombolysis. 2018 Nov; 46(4):435-439.
-
Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation. Heart. 2018 11; 104(22):1850-1858.
-
Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice: A Retrospective Cohort Study. Ann Intern Med. 2017 Dec 19; 167(12):845-854.
-
Sex Differences in the Use of Oral Anticoagulants for Atrial Fibrillation: A Report From the National Cardiovascular Data Registry (NCDR®) PINNACLE Registry. J Am Heart Assoc. 2017 Jul 19; 6(7).